(Total Views: 620)
Posted On: 11/29/2022 7:02:38 PM
Post# of 148899
Just wanted to give Flight_19's viewpoint on this. He is an individual who works and is very familiar with the FDA's validation and quality processes in Big Pharma.
"This concern (about protection of Leronlimab's formula and manufacturing) is moot IMO, since the manufacturing is being performed by Samsung. There has been a complete Tech Transfer to Samsung by CYDY for the 'recipe' to manufacture LL and is covered under licensing to manufacture and the Quality Agreement. I believe the manufacturing rights to manufacture LL are owned by CYDY and licensed to the manufacturing site under a manufacturing agreement."
"This concern (about protection of Leronlimab's formula and manufacturing) is moot IMO, since the manufacturing is being performed by Samsung. There has been a complete Tech Transfer to Samsung by CYDY for the 'recipe' to manufacture LL and is covered under licensing to manufacture and the Quality Agreement. I believe the manufacturing rights to manufacture LL are owned by CYDY and licensed to the manufacturing site under a manufacturing agreement."
(1)
(0)Scroll down for more posts ▼
